Lipella Pharmaceuticals Inc.
LIPO· Unspecified
LIPOLipella Pharmaceuticals Inc.
Filed Feb 27, 2024 · 10-K · 58 days after period end · 0001753926-24-000403
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|
| Revenue | $120.84K | $151.01K |
| Net Income | -$688.88K | -$363.92K |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipella Pharmaceuticals Inc. · CIK 1347242 · Engraved from SEC EDGAR
ended Dec 31, 2023 · filed Feb 27, 2024 · 58 d after period end
